Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China

BACKGROUND: Prostaglandin analogs (PGAs) are the first-line treatment for primary open-angle glaucoma (POAG) and ocular hypertension (OH). This study aimed to confirm the effectiveness and safety of Tapros® (0.0015% tafluprost eye drops) in Chinese patients with POAG and OH. METHODS: This phase IV,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xinghuai, Liu, Qinghuai, Tang, Xin, Yao, Ke, Li, Yan, Yang, Jin, Zhang, Mingchang, Yuan, Huiping, Zheng, Yan, Li, Weining, Peng, Huacong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356508/
https://www.ncbi.nlm.nih.gov/pubmed/35932001
http://dx.doi.org/10.1186/s12886-022-02553-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356508/
https://www.ncbi.nlm.nih.gov/pubmed/35932001
http://dx.doi.org/10.1186/s12886-022-02553-1

Ejemplares similares